22.418 articles found

[Therapeutic strategies for Parkinson's disease].

Destee A.

Rev Prat · 2005-04-01

PMID: 15966415

Obesity in Parkinson's disease patients on electrotherapy: collateral damage, adiposity rebound or secular trends?

Dulloo AG, Montani JP.

Br J Nutr · 2005-04-01

DOI: 10.1079/bjn20041337PMID: 15946401

Neuroimaging and therapeutics in movement disorders.

Eckert T, Eidelberg D.

NeuroRx · 2005-04-01

DOI: 10.1602/neurorx.2.2.361PMID: 15897956

PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF

SEKIGUCHI YOSHINORI, KANUMA KOSUKE, OMODERA KATSUNORI, TRAN THUY-ANH, SEMPLE GRAEME, KRAMER BRYAN A.

· 2005-03-29

PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF

SEKIGUCHI Yoshinori Taisho Pharma. Co Ltd., KANUMA Kosuke Taisho Pharmaceutical Co. Ltd, OMODERA Katsunori Taisho Pharma. Co.Ltd, TRAN Thuy-Anh, SEMPLE Graeme, KRAMER Bryan A..

· 2005-03-29

PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF

SEKIGUCHI YOSHINORI, KANUMA KOSUKE, OMODERA KATSUNORI, TRAN THUY-ANH, SEMPLE GRAEME, KRAMER BRYAN A.

· 2005-03-29

Pyrimidine derivatives and methods of treatment related to the use thereof

SEKIGUCHI YOSHINORI, KANUMA KOSUKE, OMODERA KATSUNORI, TRAN THUY-ANH, SEMPLE GRAEME, KRAMER BRYAN A.

· 2005-03-29

Pyrimidine derivatives and methods of treatment related to the use thereof

SEKIGUCHI YOSHINORI KANUMA KOS.

· 2005-03-29

Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment.

Milusheva E, Baranyi M, Kittel A, Sperlágh B, Vizi ES.

Free Radic Biol Med · 2005-03-25

DOI: 10.1016/j.freeradbiomed.2005.02.034PMID: 15925285

METHODS FOR IDENTIFYING AGENTS USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

RHOADES Kristina L., MA Hongwen, WONG-STAAL Flossie.

· 2005-03-23

Hydrosoluble fiber (Plantago ovata husk) and levodopa I: experimental study of the pharmacokinetic interaction.

Garcia JJ, Fernandez N, Carriedo D, Diez MJ, Sahagun A, Gonzalez A, Calle A, Sierra M.

Eur Neuropsychopharmacol · 2005-03-23

DOI: 10.1016/j.euroneuro.2005.01.005PMID: 16139166

Hydrosoluble fiber (Plantago ovata husk) and levodopa II: experimental study of the pharmacokinetic interaction in the presence of carbidopa.

Fernandez N, Carriedo D, Sierra M, Diez MJ, Sahagun A, Calle A, Gonzalez A, Garcia JJ.

Eur Neuropsychopharmacol · 2005-03-23

DOI: 10.1016/j.euroneuro.2005.01.006PMID: 16139167